Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues

Journal of Nuclear Cardiology

Volumn 8, Issue 1, 2001, Pages 75-88

  Dilsizian, Vasken ^a   Bacharach, Stephen L ^a   Khin, Maung M ^a   Smith, Mark F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; FATTY ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; OXYGEN 15; POTASSIUM 43; POTASSIUM CHLORIDE; POTASSIUM DERIVATIVE; RADIOISOTOPE; RUBIDIUM 81; RUBIDIUM 82; SODIUM IODIDE; TECHNETIUM 99M; THALLIUM 201; TRACER; WATER;

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL STUDY; CONTROLLED STUDY; CYCLOTRON; DIAGNOSTIC IMAGING; GLUCOSE UTILIZATION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART PERFORMANCE; HUMAN; IMAGING SYSTEM; ISOTOPE LABELING; ISOTOPE TRACING; MEDICAL TECHNOLOGY; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0035086622     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2001.111409     Document Type: Article

References (65)

1. Localization of brain tumors with positron emitters
2. Fluorine-18: A new isotope for bone scanning
3. Gamma-ray and positron scintillator camera
4. 43K and the gamma camera
5. Rubidium-81: A new myocardial scanning agent
6. Regional myocardial blood flow, metabolism, and function assessed noninvasively with positron emission tomography
7. Identification and differentiation of resting myocardial ischemia and infarction in man with positron emission tomography, F-18 labeled fluorodeoxyglucose and N-13 ammonia
8. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
9. 18F-FDG) myocardial tomography using a normal large field of view gamma camera
10. 18F-fluorodeoxyglucose using single photon emission computed tomography
11. Perspectives on the study of human myocardium: Viability
12. Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional state
13. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability
14. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction
15. Results of coronary artery surgery in patients with poor left ventricular function (CASS)
16. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function
17. Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease
18. Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS)
19. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers
20. Methodology governing the assessment of myocardial glucose metabolism by positron emission tomography and fluorine 18-labeled fluorodeoxyglucose
21. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography
22. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative
23. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols
24. PET imaging using gamma camera systems: A review
25. Advances in nuclear medicine instrumentation: Considerations in the design and selection of an imaging system
26. Coincidence imaging with a dual-head scintillation camera
27. Positron camera with extended counting rate capability
28. Left ventricular volume-Physical basis for attenuation corrections in radionuclide determinations
29. CT-SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal anti-body therapy of lymphoma patients
30. Optimization of collimators for imaging positron emitters by a gamma-camera
31. Performance-characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera
32. Physical performance of a multispect-2 gamma-camera for imaging positron emitters
33. Collimator characteristics and design
34. Imaging properties of a half-inch sodium iodide gamma camera
35. 18F-fluorodeoxyglucose single photon emission computed tomography: Can it replace PET and thallium SPECT for the assessment of myocardial viability?
36. Validity of F-18-fluorodeoxyglucose imaging with a dual-head coincidence gamma for detection of myocardial viability
37. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability
38. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium
39. Myocardial viability studies using fluorine-18-FDG SPECT: A comparison with fluorine-18-FDG PET
40. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography
41. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG
42. Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: An alternative for determining myocardial viability
43. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction severe left ventricular dysfunction and healed myocardial infarction
44. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
45. Attenuation correction in cardiac positron emission tomography and single-photon emission computed-tomography
46. The physics of positron emission tomography
47. Transmission scanning system for a gamma camera coincidence scanner
48. Image fusion using an integrated, dual-headed coincidence camera with x-ray tube-based attenuation maps
49. Cardiac fluorine-18 fluorodeoxyglucose imaging using a dual-head gamma camera with coincidence detection: A clinical pilot study
50. Cardiac imaging with gamma camera coincidence (hybrid) PET
51. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201
52. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging
53. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely ventricular function
54. Incremental prognostic value of thallium reinjection after stress redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction
55. Stress-induced reversible and mild-to-moderate irreversible thallium defects: Are they equally accurate for predicting recovery of regional left ventricular function after revascularization?
56. Thallium-201 scintigraphy: Experience of two decades
57. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with F-18 fluorodeoxyglucose
58. Predicting recovery of severe regional ventricular dysfunction: Comparison of resting scintigraphy with T1-201 and Tc-99m sestamibi
59. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects
60. 99mTc-MIBI SPET: A comparative study in patients with coronary artery disease
61. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: Comparison with fluorine-18-FDG PET
62. Comparison of sestamibi single-photon emission tomography with positron emission tomography for estimating left ventricular myocardial viability
63. Assessment of myocardial perfusion and viability with technetium-99m methoxybutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease
64. 99mTc-sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris or both
65. F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization